Abstract
Purpose: Intestinal obstruction leads to an increase in the secretion of pro-inflammatory and inflammatory cytokines, oxidative injury, mucosal barrier dysfunction and bacterial translocation with the deterioration of normal ecological balance. Mitogenic activity resulting from splenectomy is reported to influence the development of bacterial translocation as a result of an increase in the proliferation of T cells and a decrease in the levels of serum tufsin. In this study, we aimed to investigate the effect of splenectomy on bacterial translocation and inflammatory response alterations resulting from the intestinal obstruction in rats.
Materials and Methods: Twenty-four rats were divided into 3 groups as follows: Group 1 (Sham), only the ileocecal junction dissection; Group 2 (intestinal obstruction), complete ileal ligation; Group 3 (Splenectomy + intestinal obstruction), splenectomy following complete ileal ligation. 24 hours after the initial laparotomy, rats were sacrificed with the reception of intra-cardiac blood. Peritoneal swap, mesenteric lymph node, liver and ileal specimens, taken in sterile conditions, were examined microbiologically, biochemically and histopathologically.
Results: Intestinal obstruction resulted in a significant increase in bacterial translocation, oxidative stress, inflammation, and ileal mucosal injury (p<0.05). No significant difference occurred between the splenectomized and non-splenectomized rats. Similar asimetric dimethylarginine levels were observed in all groups (p>0.05).
Conclusions: It was proven that splenectomy has no significant effect on the bacterial translocation and inflammation in experimental intestinal obstruction models in rats.
Keywords:
Intestinal obstruction, splenectomy, bacterial translocation
References
1Theodorou D, Geli P, Makrkogiannakis H, et al. Protection of intestinal permeability in the perioperative period. J Clin Gastroenterol 2009; 43:500. doi:10.1097/ MCG.0b013e318182c2fa
2Demirkan A, Aksoy M, Kuzu MA, ve ark. Deneysel ileusda indometasin kullanımının intestinal permeabilite ve bakteriyel translokasyon üzerine etkileri. Ankara Üniversitesi Tıp Fakültesi Mecmuası 2006; 59:119–127.
3Cevikel MH, Özgün H, Boylu S, et al. C-reactive protein may be a marker of bacterial translocation in experimental intestinal obstruction. ANZ J Surg 2004; 74:900– 904. doi:10.1111/j.1445-1433.2003.02681.x
4Nijveldt RJ, Teerlink T, Van Der Hoven B, et al. Asymmetrical dimethylarginine (ADMA) in critically ill patients: high plasma ADMA concentration is an independent risk factor of ICU mortality. Clin Nutr 2003; 22:23–30. doi:10.1054/ clnu.2002.0613
5Engin A. Genel Cerrahi Tanı ve Tedavi İlkeleri. Atlas Kitapçılık. 2000; 671–684.
6Guo W, Andersson R, Willén R, et al. Bacterial translocation after intraperitoneal implantation of rubber fragments in the splenectomized rat. J Surg Res 1994; 57:408. doi:10.1006/jsre.1994.1162
7Basoglu M, Yıldırgan MI, Polat KY, et al. Bacterial translocation after intraperitoneal draın in the splenectomized rats. T Klin J Med Sci 1998; 18:190–195.
8Olfert ED, Cross BM, McWilliam AA. Guide to the care and use of experimental animals. Canada, Canadian Council on Animal Care 1993; 1–298.
9Erel O. A new automated colorimetric method for measuring total oxidant status. Clin Biochem 2005; 38:1103–1111. doi:10.1016/j.clinbiochem.2005.08.008
10Erel O. A novel automated method to measure total antioxidant response against potent free radical reactions. Clin Biochem 2004; 37:112–119. doi:10.1016/j. clinbiochem.2003.10.014
11Eckerson HW, Romson J, Wyte C, et al. The human serum paraoxonase polymorphism: identification of phenotypes by their response to salts. Am J Hum Genet 1993; 35:214–227.
12Welch JP. General consideration and mortality in bowel obstruction. In: Welch JP, editor. Bowel obstruction: differential diagnosis and clinical management. Philadelphia: Saunders Company; 1990; 59–95.
13Wang X, Guo VD, Wang Q, et al. The association between enteric bacterial overgrowth and gastrointestinal motility after subtotal liver resection or portal vein obstruction in rats. Eur J Surg 1994; 160:153–160.
14Edmiston CE Jr, Condon RE. Bacterial translocation. Surg Gynecol Obstet 1991; 173:73–83.
15Barber AE, Jones WG, Minei JP, et al. Bacterial overgrowth and intestinal atrophy in the etiology of gut barrier failure in the rat. Am J Surg 1991; 161:300–304. doi:10.1016/0002-9610(91)91148-C
16Antequera R, Bretana A, Cirac A, et al. Disruption of the intestinal barrier and bacterial translocation in an experimental model of intestinal obstruction. Acta Cient Venez 2000; 51:18–26.
17Akcay MN, Capan MY, Gundogdu C, et al. Bacterial translocation in experimental intestinal obstruction. J Int Med Res 1996; 24:17–26.
18Aldemir M, Kokoglu OF, Geyik MF, et al. Effects of octreotide acetate and saccharomyces boulardii on bacterial translocation in an experimental intestinal loop obstruction model of rats. Tohoku J Exp Med 2002; 198:1–9. doi:10.1620/ tjem.198.1
19Baykal A, Aydın C, Hasçelik G, et al. Experimental study of the effects of splenectomy on bacterial translocation. J Trauma 1999; 46:1096–1099. doi:10.1097/00005373-199906000-00024
20Paksoy M, İpek T, Oral C, et al. The effect of granulocyte colony stimulating factor (G-CSF) on bacterial translocation in the splenectomized rat. Hepato- Gastroenterology 1997; 44:411–416.
21Spaeth G, Specian RD, Berg RD, et al. Splenectomy influences endotoxin-induced bacterial translocation. J Trauma 1990;30:1267-1272.
22Sarı M, Eroglu E, Agalar F, ve ark. The effect of splenectomy and femur fracture on bacterial translocation and liver regeneration in mice in an experimental two hit trauma model. Süleyman Demirel Üniversitesi Yaşam Dergisi 2010;2:1-6
23Bazzoni F, Beutler B. The tumor necrosis factor ligand and receptor families. N Engl J Med 1996; 334:1717–1725. doi:10.1056/NEJM199608013350512
24Goldman G, Soffer D, Heller L, et al. Tumor necrosis factor mediates bacterial translocation after haemorrhagic shock and endotoxaemia. Eur J Surg 2001; 167:299–304.
25Breese E, Michie C, Nicholls S, et al. Tumor necrosis factor a-producing cells in the intestinal mucosa of children with inflammatory bowel disease. Gastroenterology 1994; 106:1455–1466.
26Bethea JR, Chung IY, Sparacio SM, et al. Interleukin -1s induction of tumor necrosis factor -alpha gene expression in human astroglioma cells. J Neuroimmunol 1992; 36:179–190.
27Westhuyzen J, Healy H. Biology and relevance of C-reactive protein in cardiovascular and renal disease. Ann Clin Lab Sci 2000; 30:133–143. doi:10.1046/j.1440-1797.2000.abs187.x
28Li Hl, Liu DP, Liang CC. Paraoxonase gene polymorphisms, oxidative stress, and diseases. J Mol Med 2003; 81:766–779. doi:10.1056/NEJM199608013350512
29Tarpey MM, Wink DA, Grisham MB. Methods for detection of reactive metabolites of oxygen and nitrogen: in vitro and in vivo considerations. Am J Physiol Regul Integr Comp Physiol 2004; 286:431–
30doi:10.1152/ajpregu.00361.2003
31Dabareiner RM, Sullins KE, Snyder JR. Evaluation of the microcirculation of the equine small intestine after intraluminal distention and subsequent decompression. Am J Vet Res 1993; 54:1673–1682.
32Nellgard P, Jonsson A, Bojo L, et al. Smallbowel obstruction and the effects of lidocaine, atropine and hexamethonium on inflammation and fluid losses. Acta Anaesthesiol Scand 1996; 40:287–292.
33Van Hoorn EC, Van Middelaar-Voskuilen MC, et al. Preoperative supplementation with a carbohydrate mixture decreases organ dysfunction-associated risk factors. Clinical Nutrition 2005; 24:114–123. doi:10.1016/j.clnu.2004.08.002
